FDA Class II Device Recall: GEM Premier 5000
Summary
The FDA has issued an ongoing Class II device recall for Instrumentation Laboratory's GEM Premier 5000 due to customer complaints of Process Control Solution Not Detected (PCSND) errors. This recall affects worldwide distribution, including the US.
What changed
The FDA has classified a recall of the GEM Premier 5000 device (Part No. 00055415005) as Class II, indicating that use of or exposure to a defective product may cause adverse health consequences that are temporary or medically reversible. The issue stems from confirmed customer complaints reporting an increased incidence of 'Process Control Solution Not Detected' (PCSND) errors during the warm-up phase of GEM PAKs (cartridges), leading to GEM PAK ejection and requiring re-insertion.
Manufacturers and distributors involved in the worldwide distribution of this device, including within the US, must ensure compliance with recall procedures. While the document does not specify immediate actions for end-users beyond the recall itself, affected parties should be aware of the potential for device malfunction and the need for prompt resolution by the manufacturer. The recall is ongoing, and further information may be available through the FDA's openFDA Enforcement API.
What to do next
- Review recall procedures for GEM Premier 5000 devices
- Monitor FDA communications regarding recall status
Source document (simplified)
Instrumentation Laboratory
Device Recalls (Class II)
← All Device Recalls (Class II) Class II Z-1533-2026 · 20260318 · Ongoing
Product
GEM Premier 5000; Part No. 00055415005.
Reason for Recall
Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...
Distribution
Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...
Source: openFDA Enforcement API
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Device Recalls Class II publishes new changes.